13Jul 2023
Lateral Transcervical In‐office Botulinum Toxin Injection for Retrograde Cricopharyngeal Dysfunction

Lateral Transcervical In‐office Botulinum Toxin Injection for Retrograde Cricopharyngeal Dysfunction

A study analyzed the effectiveness and safety of in-office (IO) injections of botulinum toxin (BTX) into the cricopharyngeus muscle for the management of retrograde cricopharyngeal dysfunction (RCPD). The success rate of Operating room (OR) injections was significantly higher (90.2%) than IO injections (64.9%) at the first-month follow-up. However, the two groups had no significant difference in side effects. The study concluded that IO BTX injections are safe and convenient but have lower success rates than OR injections for RCPD.

  • #ent

Like

Save

Share